Literature DB >> 34370485

String-Attached Oligothiophene Substituents Determine the Fate of Excited States in Ruthenium Complexes for Photodynamic Therapy.

Avinash Chettri1,2, Kilian R A Schneider1,2, Houston D Cole3, John A Roque3,4, Colin G Cameron3, Sherri A McFarland3, Benjamin Dietzek1,2.   

Abstract

We explore the photophysical properties of a family of Ru(II) complexes, Ru-ip-nT, designed as photosensitizers (PSs) for photodynamic therapy (PDT). The complexes incorporate a 1H-imidazo[4,5-f][1,10]-phenanthroline (ip) ligand appended to one or more thiophene rings. One of the complexes studied herein, Ru-ip-3T (known as TLD1433), is currently in phase II human clinical trials for treating bladder cancer by PDT. The potent photocytotoxicity of Ru-ip-3T is attributed to a long-lived intraligand charge-transfer triplet state. The accessibility of this state changes upon varying the length (n) of the oligothiophene substituent. In this paper, we highlight the impact of n on the ultrafast photoinduced dynamics in Ru-ip-nT, leading to the formation of the function-determining long-lived state. Femtosecond time-resolved transient absorption combined with resonance Raman data was used to map the excited-state relaxation processes from the Franck-Condon point of absorption to the formation of the lowest-energy triplet excited state, which is a triplet metal-to-ligand charge-transfer excited state for Ru-ip-0T-1T and an oligothienyl-localized triplet intraligand charge-transfer excited state for Ru-ip-2T-4T. We establish the structure-activity relationships with regard to changes in the excited-state dynamics as a function of thiophene chain length, which alters the photophysics of the complexes and presumably impacts the photocytotoxicity of these PSs.

Entities:  

Year:  2021        PMID: 34370485      PMCID: PMC8388849          DOI: 10.1021/acs.jpca.1c04900

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.944


  26 in total

Review 1.  The photobiology of photodynamic therapy: cellular targets and mechanisms.

Authors:  N L Oleinick; H H Evans
Journal:  Radiat Res       Date:  1998-11       Impact factor: 2.841

2.  Tuning of photocatalytic hydrogen production and photoinduced intramolecular electron transfer rates by regioselective bridging ligand substitution.

Authors:  Michael Karnahl; Christian Kuhnt; Fei Ma; Arkady Yartsev; Michael Schmitt; Benjamin Dietzek; Sven Rau; Jürgen Popp
Journal:  Chemphyschem       Date:  2011-06-16       Impact factor: 3.102

3.  Femtosecond Dynamics of Excited-State Evolution in

Authors: 
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

4.  Ultrafast fluorescence detection in tris(2,2'-bipyridine)ruthenium(II) complex in solution: relaxation dynamics involving higher excited states.

Authors:  Achikanath C Bhasikuttan; Masaya Suzuki; Satoru Nakashima; Tadashi Okada
Journal:  J Am Chem Soc       Date:  2002-07-17       Impact factor: 15.419

Review 5.  Cancer revoked: oncogenes as therapeutic targets.

Authors:  Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

6.  Strained ruthenium metal-organic dyads as photocisplatin agents with dual action.

Authors:  Tariq Sainuddin; Mitch Pinto; Huimin Yin; Marc Hetu; Julie Colpitts; Sherri A McFarland
Journal:  J Inorg Biochem       Date:  2016-01-09       Impact factor: 4.155

7.  Carbene based photochemical molecular assemblies for solar driven hydrogen generation.

Authors:  Katrin Peuntinger; T David Pilz; Robert Staehle; Markus Schaub; Simon Kaufhold; Lydia Petermann; Markus Wunderlin; Helmar Görls; Frank W Heinemann; Jing Li; Thomas Drewello; Johannes G Vos; Dirk M Guldi; Sven Rau
Journal:  Dalton Trans       Date:  2014-09-28       Impact factor: 4.390

Review 8.  Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?

Authors:  Sherri A McFarland; Arkady Mandel; Roger Dumoulin-White; Gilles Gasser
Journal:  Curr Opin Chem Biol       Date:  2019-11-20       Impact factor: 8.822

9.  Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.

Authors:  Susan Monro; Katsuya L Colón; Huimin Yin; John Roque; Prathyusha Konda; Shashi Gujar; Randolph P Thummel; Lothar Lilge; Colin G Cameron; Sherri A McFarland
Journal:  Chem Rev       Date:  2018-10-08       Impact factor: 60.622

10.  Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy.

Authors:  John A Roque; Patrick C Barrett; Houston D Cole; Liubov M Lifshits; Ge Shi; Susan Monro; David von Dohlen; Susy Kim; Nino Russo; Gagan Deep; Colin G Cameron; Marta E Alberto; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-08-03       Impact factor: 9.825

View more
  1 in total

1.  Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy.

Authors:  Avinash Chettri; Houston D Cole; John A Roque Iii; Kilian R A Schneider; Tingxiang Yang; Colin G Cameron; Sherri A McFarland; Benjamin Dietzek-Ivanšić
Journal:  J Phys Chem A       Date:  2022-02-18       Impact factor: 2.781

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.